UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q/A
(Amendment No. 1)

[X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE
SECURITIES EXCHANGE ACT OF 1934

For The Quarterly Period Ended May 29, 2004

OR
    
[ ]   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE
SECURITIES EXCHANGE ACT OF 1934

For The Transition Period From              To                 
Commission File Number 1-5742

RITE AID CORPORATION

(Exact name of registrant as specified in its charter)


Delaware 23-1614034
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
   
30 Hunter Lane,
Camp Hill, Pennsylvania
(Address of principal executive offices)
17011
(Zip Code)

Registrant's telephone number, including area code: (717) 761-2633

(Former name, former address and former fiscal year, if changed since last report) Not Applicable

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months, and (2) has been subject to such filing requirements for the past 90 days. Yes  [X]    No  [ ]

Indicate by check whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes  [X]    No  [ ]

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.

The registrant had 517,294,655 shares of its $1.00 par value common stock outstanding as of June 22, 2004.




RITE AID CORPORATION

TABLE OF CONTENTS


    Page
  Explanatory Statement   3  
  Cautionary Statement Regarding Forward Looking Statements   4  
  PART I
FINANCIAL INFORMATION
     
ITEM 1. Financial Statements (unaudited):
  Condensed Consolidated Balance Sheets as of May 29, 2004 and
February 28, 2004
  5  
  Condensed Consolidated Statements of Operations for the Thirteen Week Periods Ended May 29, 2004 and May 31, 2003   6  
  Condensed Consolidated Statements of Cash Flows for the Thirteen Week Periods Ended May 29, 2004 and May 31, 2003   7  
  Notes to Condensed Consolidated Financial Statements   8  
ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations   18  
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk   24  
ITEM 4. Controls and Procedures   25  
  PART II
OTHER INFORMATION
     
ITEM 1. Legal Proceedings   26  
ITEM 2. Changes in Securities, Use of Proceeds and Issuer Purchases of Equity Securities   26  
ITEM 3. Defaults Upon Senior Securities   26  
ITEM 4. Submission of Matters to a Vote of Security Holders   26  
ITEM 5. Other Information   26  
ITEM 6. Exhibits and Reports on Form 8-K   27  
         
         

2




EXPLANATORY STATEMENT

As previously disclosed in our Current Report on Form 8-K dated March 18, 2005, on March 17, 2005, our management and audit committee of the Board of Directors have determined that our financial statements for each of the three years in the period ended February 28, 2004 and for the first three quarters of fiscal 2005 should be restated.

On February 7, 2005, a letter was issued by the Office of the Chief Accountant of the Securities and Exchange Commission ("SEC") to the American Institute of Certified Public Accountants that clarified the application of generally accepted accounting principles ("GAAP") for lease accounting. This letter led to our review of certain leasing transactions. As a result of our review, we have determined that our methods of accounting for rent during construction periods and amortization of leasehold improvements for a small number of stores were not consistent with GAAP. Historically, we recorded rent expense on stores at the time that the store began operations. We have now determined that we should have recorded rent expense at the time that we had the right to use the property, which typically is when we begin construction on the property. We also had leasehold improvements at a small number of stores that were being depreciated over lives longer than the minimum lease term of the related ground lease. We have now determined that we should be amortizing these improvements over a life that is no longer than the minimum lease term.

These non-cash adjustments, which are similar to others recently announced by several restaurant and retail companies, will have no impact on historical or future cash flows or the timing of payments under our operating leases. Also, they have no impact on our financial covenants under our senior secured credit facility.

This Amendment No. 1 on Form 10-Q/A ("Form 10-Q/A") to our Quarterly Report on Form 10-Q for the quarterly period ended May 29, 2004, initially filed with the SEC on June 29, 2004 (the "Original Filing") is being filed to reflect the restatement of our condensed consolidated financial statements for the quarters ended May 29, 2004 and May 31, 2003. For a more detailed description of these restatement, see Note 11, "Restatement of Financial Statements," to the accompanying condensed consolidated financial statements.

For the convenience of the reader, this Form 10-Q/A sets forth the Original Filing in its entirety. However, this Form 10-Q/A only amends and restates certain information in Items 1, 2 and 4 of Part I of the Original Filing, in each case, solely as a result of, and to reflect the restatement, and no other information in the Original Filing is amended hereby. The foregoing items have not been updated to reflect other events occurring after the Original Filing or to modify or update those disclosures affected by subsequent events. In addition, pursuant to the rules of the SEC, Item 6 of Part II of the Original Filing has been amended to contain currently dated certifications from our Chief Executive Officer and Chief Financial Officer, as required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002. The certifications of our Chief Executive Officer and Chief Financial Officer are attached to this Form 10-Q/A as exhibits 31.1, 31.2 and 32, respectively.

Except for the foregoing amended information, this Form 10-Q/A continues to describe conditions as of the date of the Original Filing, and we have not updated the disclosures contained herein to reflect events that occurred at a later date. We have not amended and do not intend to amend our previously filed Annual Reports on Form 10-K or our Quarterly Reports on Form 10-Q for the periods affected by the restatement that ended prior to February 28, 2004. For this reason, the consolidated financial statements, auditors reports and related financial information for the affected periods contained in such reports should no longer be relied upon.

3




CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This report includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are identified by terms and phrases such as "anticipate," "believe," "intend," "estimate," "expect," "continue," "should," "could," "may," "plan," "project," "predict," "will" and similar expressions and include references to assumptions and relate to our future prospects, developments and business strategies.

Factors that could cause actual results to differ materially from those expressed or implied in such forward-looking statements include, but are not limited to:

•  our high level of indebtedness;
•  our ability to make interest and principal payments on our debt and satisfy the other covenants contained in our senior secured credit facility and other debt agreements;
•  our ability to improve the operating performance of our existing stores in accordance with our management's long term strategy;
•  our ability to hire and retain pharmacists and other store personnel;
•  the outcomes of pending lawsuits and governmental investigations;
•  competitive pricing pressures and continued consolidation of the drugstore industry; and
•  the efforts of third party payors to reduce prescription drug reimbursements, changes in state or federal legislation or regulations, the success of planned advertising and merchandising strategies, general economic conditions and inflation, interest rate movements, access to capital, and our relationships with our suppliers.

We undertake no obligation to revise the forward-looking statements included in this report to reflect any future events or circumstances. Our actual results, performance or achievements could differ materially from the results expressed in, or implied by, these forward-looking statements. Factors that could cause or contribute to such differences are discussed in the section entitled "Management's Discussion and Analysis of Financial Condition and Results of Operations—Overview and Factors Affecting Our Future Prospects" included in our Annual Report on Form 10-K/A for the fiscal year ended February 28, 2004 ("the Fiscal 2004 10-K/A"), which we filed with the Securities and Exchange Commission ("SEC") on April 6, 2005 and is available on the SEC's website at www.sec.gov.

4




PART I. FINANCIAL INFORMATION

ITEM 1.    Financial Statements

RITE AID CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except per share amounts)
(unaudited)


  May 29,
2004
(as restated,
see note 11)
February 28,
2004
ASSETS            
Current assets:            
Cash and cash equivalents $ 500,151   $ 334,755  
Accounts receivable, net   649,492     670,004  
Inventories, net   2,250,627     2,223,171  
Prepaid expenses and other current assets   100,774     150,067  
Total current assets   3,501,044     3,377,997  
Property, plant and equipment, net   1,861,465     1,882,763  
Goodwill   684,535     684,535  
Other intangibles, net   177,058     176,672  
Other assets   134,929     123,667  
Total assets $ 6,359,031   $ 6,245,634  
             
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)            
Current liabilities:            
Current maturities of long-term debt and lease financing obligations $ 220,781   $ 23,976  
Accounts payable   828,524     758,290  
Accrued salaries, wages and other current liabilities   700,297     701,484  
Total current liabilities   1,749,602     1,483,750  
Convertible notes   246,375     246,000  
Long-term debt, less current maturities   3,250,799     3,451,352  
Lease financing obligations, less current maturities   171,610     170,338  
Other noncurrent liabilities   879,302     902,471  
Total liabilities   6,297,688     6,253,911  
Commitments and contingencies        
Stockholders' equity (deficit):            
Preferred stock, par value $1 per share, liquidation value $100 per share   426,159     417,803  
Common stock, par value $1 per share   517,297     516,496  
Additional paid-in capital   3,130,021     3,133,277  
Accumulated deficit   (3,989,255   (4,052,974
Accumulated other comprehensive loss   (22,879   (22,879
Total stockholders' equity (deficit)   61,343     (8,277
Total liabilities and stockholders' equity (deficit) $ 6,359,031   $ 6,245,634  

See accompanying notes to condensed consolidated financial statements.

5




RITE AID CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
(unaudited)


  Thirteen Week Period Ended
  May 29,
2004
(as restated,
see note 11)
May 31,
2003
(as restated,
see note 11)
Revenues $ 4,244,357   $ 4,046,168  
Costs and expenses:
Cost of goods sold, including occupancy costs   3,191,456     3,068,214  
Selling, general and administrative expenses   908,863     889,733  
Stock-based compensation expense   3,982     9,835  
Store closing and impairment (credits) charges   (4,595   6,246  
Interest expense   77,801     78,958  
Loss on debt modifications and retirements, net       33,427  
Gain on sale of assets and investments, net   (1,918   (1,504
    4,175,589     4,084,909  
Income (loss) before income taxes   68,768     (38,741
Income tax expense   5,049      
Net income (loss) $ 63,719   $ (38,741
Computation of income (loss) applicable to common stockholders:
Net income (loss) $ 63,719   $ (38,741
Accretion of redeemable preferred stock   (26   (26
Cumulative preferred stock dividends   (8,356    
Income (loss) attributable to common stockholders $ 55,337   $ (38,767
Basic and diluted income (loss) per share:
Basic income (loss) per share $ 0.11   $ (0.08
Diluted income (loss) per share $ 0.10   $ (0.08

See accompanying notes to condensed consolidated financial statements.

6




RITE AID CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(unaudited)


  Thirteen Week Period Ended
  May 29,
2004
(as restated,
see note 11)
May 31,
2003
(as restated,
see note 11)
Operating activities:
Net income (loss) $ 63,719   $ (38,741
Adjustments to reconcile to net cash provided by operating activities:
Depreciation and amortization   63,192     65,649  
Stock-based compensation expense   3,982     9,835  
Store closing and impairment (credits) charges   (4,595   6,246  
Loss on debt modifications and retirements, net       33,427  
Gain on sale of assets and investments, net   (1,918   (1,504
Changes in income tax receivables and payables   41,279      
Changes in operating assets and liabilities   50,900     (25,112
Net cash provided by operating activities   216,559     49,800  
Investing activities:
Expenditures for property, plant and equipment   (35,088   (128,760
Intangible assets acquired   (6,730   (4,895
Proceeds from dispositions of assets and investments   3,483     8,523  
Net cash used in investing activities   (38,335   (125,132
Financing activities:
Principal payments on long-term debt   (6,162   (185,464
Principal payments on bank credit facilities       (1,372,500
Proceeds from issuance of new bank credit facility       1,150,000  
Change in zero balance cash accounts   (8,586   (14,971
Proceeds from issuance of stock   1,920     848  
Proceeds from issuance of bonds       502,950  
Deferred financing costs paid       (28,110
Net cash (used in) provided by financing activities   (12,828   52,753  
Increase (decrease) in cash and cash equivalents   165,396     (22,579
Cash and cash equivalents at beginning of period   334,755     365,321  
Cash and cash equivalents at end of period $ 500,151   $ 342,742  
Supplementary cash flow data:
Cash paid for interest (net of capitalized amounts of $44 and $48) $ 52,152   $ 61,205  
Cash refunds of income taxes, net $ (35,982 $ (413

See accompanying notes to condensed consolidated financial statements.

7




RITE AID CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Thirteen Week Periods Ended May 29, 2004 and May 31, 2003
(Dollars and share information in thousands, except per share amounts)
(unaudited)

1.    Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X and therefore do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete annual financial statements. The accompanying financial information reflects all adjustments (consisting primarily of normal recurring adjustments except as described in these notes) which are, in the opinion of management, necessary for a fair presentation of the results for the interim periods. The results of operations for the thirteen week period ended May 29, 2004 are not necessarily indicative of the results to be expected for the full year. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company's Fiscal 2004 Annual Report on Form 10-K/A filed with the SEC.

2.    Recent Accounting Pronouncements

Effective March 2, 2003, the Company adopted the fair value recognition provisions of SFAS No. 123, "Accounting for Stock-Based Compensation". Under the modified prospective method of adoption selected by the Company under provisions of SFAS No. 148, "Accounting for Stock-Based Compensation — Transition and Disclosure" compensation expense recognized in fiscal 2004 is the same as that which would have been recognized had the recognition provisions of SFAS No. 123 been applied from its original effective date.

In January 2003, the Financial Accounting Standards Board ("FASB") issued Interpretation ("FIN") No. 46, "Consolidation of Variable Interest Entities", subject to certain effective date deferrals. FIN No. 46 requires the consolidation of entities that cannot finance their activities without the support of other parties and that lack certain characteristics of a controlling interest, such as the ability to make decisions about the entity's activities via voting rights or similar rights. The entity that consolidates the variable interest entity is the primary beneficiary of the entity's activities. FIN No. 46 applies immediately to variable interest entities created after January 31, 2003, and must be applied in the first period ending after December 15, 2003 for entities in which an enterprise holds a variable interest entity that it acquired before February 1, 2003. The adoption of FIN No. 46 did not have a material impact on the Company's financial position or results of operations. In December of 2003, the FASB revised FIN 46 ("FIN 46R"), which delayed the required implementation date for variable interest entities until the end of the first reporting period that ends after March 15, 2004. FIN 46R applied to the Company's financial statements for the period ended May 29, 2004. The adoption of FIN 46R did not have a material impact on the Company's financial position or results of operations.

8




3.    Income (Loss) Per Share

Following is a summary of the components of the numerator and denominator of the basic and diluted income (loss) per share computation:


  Thirteen Week Period Ended
  May 29,
2004
May 31,
2003
Numerator for income (loss) per share:            
Net income (loss) $ 63,719   $ (38,741
Accretion of redeemable preferred stock   (26   (26
Cumulative preferred stock dividends   (8,356    
             
Income (loss) attributable to common stockholders – basic   55,337     (38,767
             
Interest on convertible debt   2,968      
             
Income (loss) attributable to common shareholders –     diluted $ 58,305   $ (38,767
             
Denominator:            
Basic weighted average shares   516,837     515,198  
Outstanding options   18,792      
Convertible debt   38,462      
             
Diluted weighted average shares   574,091     515,198  
             
Basic and diluted income (loss) per share:            
    Basic net income (loss) per share $ 0.11   $ (0.08
    Diluted net income (loss) per share $ 0.10   $ (0.08

Diluted weighted average shares for the thirteen week period ended May 29, 2004 do not reflect potential dilutive common shares related to convertible preferred stock, as inclusion of these shares would be antidilutive. No potential shares of common stock have been included in the computation of diluted earnings per share for the thirteen week period ended May 31, 2003, as inclusion of these shares would be antidilutive. At May 29, 2004, an aggregate of 92,286 potential common shares related to stock options with exercise prices greater than average market price of the common stock during the period and convertible preferred stock have been excluded from the computation of diluted earnings per share. At May 31, 2003, an aggregate of 173,836 potential dilutive common shares related to stock options, convertible notes and preferred stock have been excluded from the computation of diluted earnings per share.

4.    Store Closing and Impairment Charges

Store closing and impairment (credits) charges consist of:


  Thirteen Week Period Ended
  May 29,
2004
May 31,
2003
Impairment charges $ 829   $ 831  
Store and equipment lease exit (credits) charges   (5,424   5,415  
  $ (4,595 $ 6,246  

9




Impairment charges

Impairment charges include non-cash charges of $829 and $831 for the thirteen week periods ended May 29, 2004 and May 31, 2003, respectively, for the impairment of long-lived assets at 11 stores, in each period. These amounts include the write-down of long-lived assets at stores that were assessed for impairment because of management's intention to relocate or close the store.

Store and equipment lease exit charges (credits)

During the thirteen week periods ended May 29, 2004 and May 31, 2003, the Company recorded charges for one closed store in each period. Charges to close a store, which principally consist of lease termination costs, are recorded at the time the store is closed and all inventory is liquidated, pursuant to the guidance set forth in SFAS No. 146, "Accounting for Costs Associated with Exit or Disposal Activities". The Company calculates its liability for closed stores on a store-by-store basis. The calculation includes future minimum lease payments and related ancillary costs, from the date of closure to the end of the remaining lease term, net of estimated cost recoveries that may be achieved through subletting properties or through favorable lease terminations. This liability is discounted using a risk-free rate of interest. The Company evaluates these assumptions each quarter and adjusts the liability accordingly. The Company recorded a net closed store credit of $5,416 in the thirteen week period ended May 29, 2004, due primarily to the impact of adjustments to the risk-free rate of interest on the provision. The Company recorded net closed store expense of $5,535 in the thirteen week period ended May 31, 2003, due to the impact of interest accretion and adjustments to the risk-free rate of interest on the provision.

The reserve for store and equipment lease exit costs includes the following activity:


  Thirteen Week Period Ended  
  May 29,
2004
May 31,
2003
Balance – beginning of period $ 254,361   $ 306,485  
Provision for present value of noncancellable lease payments of stores designated to be closed   3,531     (95
Changes in assumptions about future sublease income, terminations and changes in interest rates   (10,973   3,604  
Interest accretion   2,026     2,027  
Cash payments, net of sublease income   (10,916   (14,886
Balance – end of period $ 238,029   $ 297,135  

10




The Company's revenues and income (loss) from operations for the thirteen week periods ended May 29, 2004 and May 31, 2003 include results from stores that have been closed as of May 29, 2004. The revenue and operating losses of these stores for the periods are presented as follows:


  Thirteen Week Period Ended
  May 29,
2004
May 31,
2003
Revenues $ 7,610   $ 25,387  
Loss from operations   (1,858   (546

Included in loss from operations for the thirteen weeks ended May 29, 2004, are depreciation and amortization charges of $46 and closed store liquidation charges of $1,686. Included in loss from operations for the thirteen weeks ended May 31, 2003, are depreciation and amortization charges of $256 and closed store liquidation charges of $983. The above results are not necessarily indicative of the impact that these closures will have on revenues and operating results of the Company in the future, as the Company usually transfers the business of a closed store to another Company store, thereby retaining a portion of these revenues.

5.    Goodwill and Other Intangibles

The Company evaluates goodwill for impairment on an annual basis, pursuant to the provisions of SFAS No. 142, "Goodwill and Other Intangibles." Intangible assets other than goodwill are finite-lived and amortized over their useful lives. Following is a summary of the Company's amortizable intangible assets as of May 29, 2004 and February 28, 2004.


  May 29, 2004 February 28, 2004
  Gross
Carrying
Amount
Accumulated
Amortization
Gross
Carrying
Amount
Accumulated
Amortization
Favorable leases and other $ 301,523   $ (176,208 $ 298,475   $ (173,774
Prescription files   354,121     (302,378   350,501     (298,530
Total $ 655,644   $ (478,586 $ 648,976   $ (472,304

Amortization expense for these intangible assets was $6,284 for the thirteen weeks ended May 29, 2004. The anticipated annual amortization expense for these intangible assets is 2005 – $20,503, 2006 – $16,701, 2007 – $18,617, 2008 – $16,598 and 2009 – $13,458.

6.    Income Taxes

The Company recorded income tax expense of $5,049 for the thirteen week period ended May 29, 2004 and no income tax expense or benefit for the thirteen week period ended May 31, 2003.

The provision for income taxes for the thirteen week period ended May 29, 2004 is for state and local income taxes. The expected federal income tax expense has been fully offset by utilization of net operating loss carryforwards resulting in the reduction of previously recorded valuation allowances.

The income tax benefit of the operating loss generated in the thirteen week period ended May 31, 2003 has been fully offset by a valuation allowance as a result of the Company's determination that, based on available evidence, it is more likely than not that the deferred tax assets will not be realized.

The Company has undergone an ownership change for statutory purposes during fiscal 2002, which resulted in a limitation on the future use of net operating loss carryforwards. The Company believes that this limitation does not further impair the net operating loss carryforwards because they are fully reserved.

11




7.    Indebtedness and Credit Agreements

General

Following is a summary of indebtedness and lease financing obligations at May 29, 2004 and February 28, 2004:


  May 29, 2004 February 28, 2004
Secured Debt:            
Senior secured credit facility due April 2008 $ 1,150,000   $ 1,150,000  
12.5% senior secured notes due September 2006 ($142,025 face value less unamortized discount of $3,768 and $4,158)   138,257     137,867  
8.125% senior secured notes due May 2010 ($360,000 face value less unamortized discount of $4,001 and $4,168)   355,999     355,832  
9.5% senior secured notes due February 2011   300,000     300,000  
Other   2,688     5,125  
    1,946,944     1,948,824  
Lease Financing Obligations   182,513     183,169  
Unsecured Debt:            
7.625% senior notes due April 2005   198,000     198,000  
6.0% fixed-rate senior notes due December 2005   38,047     38,047  
4.75% convertible notes due December 2006 ($250,000 face value less unamortized discount of $3,625 and $4,000)   246,375     246,000  
    7.125% notes due January 2007   210,074     210,074  
11.25% senior notes due July 2008   150,000     150,000  
6.125% fixed-rate senior notes due December 2008   150,000     150,000  
9.25% senior notes due June 2013 ($150,000 face value less unamortized discount of $2,161 and $2,221)   147,839     147,779  
6.875% senior debentures due August 2013   184,773     184,773  
7.7% notes due February 2027   295,000     295,000  
6.875% fixed-rate senior notes due December 2028   140,000     140,000  
    1,760,108     1,759,673  
Total debt   3,889,565     3,891,666  
Current maturities of long-term debt and lease financing     obligations   (220,781   (23,976
Long-term debt and lease financing obligations, less current     maturities $ 3,668,784   $ 3,867,690  

Credit Facility

The senior secured credit facility consists of a $1,150,000 term loan and a $700,000 revolving credit facility, and will mature on April 30, 2008. Borrowings under the senior secured credit facility currently bear interest either at LIBOR plus 3.00% for the term loan and 3.50% for the revolving credit facility, if the Company chooses to make LIBOR borrowings, or at Citibank's base rate plus 2.00% for the term loan and 2.50% for the revolving credit facility. The Company is required to pay fees of 0.50% per annum on the daily unused amount of the revolving facility. Amortization payments of $2,875 related to the term loan began on May 31, 2004, and continue on a quarterly basis until February 28, 2008, with a final payment of $1,104,000 due April 30, 2008.

The Company's ability to borrow under the senior secured credit facility is based on a specified borrowing base consisting of eligible accounts receivable, inventory and prescription files. At May 29, 2004, the term loan was fully drawn and the Company had no outstanding draws on the revolving credit facility. At May 29, 2004, the Company had additional borrowing capacity of $573,242, net of outstanding letters of credit of $126,758.

12




Substantially all of Rite Aid Corporation's wholly owned subsidiaries guarantee the obligations under the senior secured credit facility. The subsidiary guarantees are secured by a first priority lien on, among other things, the inventory, accounts receivable and prescription files of the subsidiary guarantors. Rite Aid Corporation is a holding company with no direct operations and is dependent upon dividends, distributions and other payments from its subsidiaries to service payments under the new senior secured credit facility. Rite Aid Corporation's direct obligations under the senior secured credit facility are unsecured.

The senior secured credit facility allows for the issuance of up to $150,000 in additional term loans or additional revolver availability. The Company may request the additional loans at any time prior to the maturity of the senior secured credit facility, provided that the Company is not in default of any terms of the facility, nor is in violation of any financial covenants. The senior secured credit facility allows the Company to have outstanding, at any time, up to $1,000,000 in secured debt in addition to the senior secured credit facility. At May 29, 2004, the remaining additional permitted secured debt under the new senior credit facility is $197,975. The Company has the ability to incur an unlimited amount of unsecured debt, if the terms of such unsecured indebtedness comply with certain terms set forth in the credit agreement and subject to the Company's compliance with certain financial covenants. If the Company issues unsecured debt that does not meet the credit agreement restrictions, it reduces the amount of available permitted secured debt. The senior secured credit facility also allows for the repurchase of any debt with a maturity prior to April 30, 2008, and for $200,000 of debt with a maturity after April 30, 2008, plus an additional amount based upon outstanding borrowings under the revolving credit facility and available cash at the time of the repurchase.

The senior secured credit facility contains customary covenants, which place restrictions on incurrence of debt, the payment of dividends, mergers, liens and sale and leaseback transactions. The senior secured credit facility also requires the Company to meet various financial ratios and limits capital expenditures. For the twelve months ending February 26, 2005, the covenants require the Company to maintain a maximum leverage ratio of 6.05:1. Subsequent to February 26, 2005, the ratio gradually decreases to 3.8:1 for the twelve months ending March 1, 2008. The Company must also maintain a minimum interest coverage ratio of 2.05:1 for the twelve months ending February 26, 2005. Subsequent to February 26, 2005, the ratio gradually increases to 3.25:1 for the twelve months ending March 1, 2008. In addition, the Company must maintain a minimum fixed charge ratio of 1.10:1 for the twelve months ending February 26, 2005. Subsequent to the period ending February 26, 2005, the ratio gradually increases to 1.25:1 for the twelve months ending March 1, 2008. Capital expenditures are limited to $386,085 for the fiscal year ending February 26, 2005.

The Company was in compliance with the covenants of the senior secured credit facility and its other debt instruments as of May 29, 2004. With continuing improvements in operating performance, the Company anticipates that it will remain in compliance with its debt covenants. However, variations in operating performance and unanticipated developments may adversely affect the Company's ability to remain in compliance with the applicable debt maintenance covenants.

The senior secured credit facility provides for customary events of default, including nonpayment, misrepresentation, breach of covenants and bankruptcy. It is also an event of default if any event occurs that enables, or which with the giving of notice or the lapse of time would enable, the holder of the Company's debt to accelerate the maturity of debt having a principal amount in excess of $25,000.

As a result of the placement of the senior secured credit facility on May 28, 2003, the Company recorded a loss on debt modification in the thirteen week period ended May 31, 2003 of $43,197 (which included the write-off of previously deferred debt issue costs of $35,120).

13




Other Transactions

During the thirteen week period ended May 31, 2003, the Company made open market purchases of the following debt securities:


Debt Redeemed Principal
Amount
Redeemed
Amount
Paid
Gain
6.0% fixed rate senior notes due 2005 $ 37,848   $ 36,853   $ 865  
7.125% notes due 2007   124,926     120,216     4,314  
6.875% senior debentures due 2013   15,227     13,144     1,981  
7.7% notes due 2027   5,000     4,219     715  
6.875% fixed rate senior notes due 2028   10,000     7,975     1,895  
Total $ 193,001   $ 182,407   $ 9,770  

The gain on the transactions listed above is recorded as part of the loss on debt modification in the accompanying statement of operations for the thirteen week period ended May 31, 2003.

Other

The aggregate annual principal payments of long-term debt for the remainder of fiscal 2005 and the succeeding four fiscal years are as follows: 2005 – $9,002, 2006 – $250,794, 2007 – $606,649, 2008 – $12,371, 2009 – $1,404,092, and $1,424,144 in 2010 and thereafter. The Company is in compliance with restrictions and limitations included in the provisions of various loan and credit agreements.

Rite Aid Corporation's direct obligations under the senior credit facility are unsecured. The 12.5% senior secured notes due 2006, the 8.125% senior secured notes due 2010 and the 9.5% senior secured notes due 2011 are guaranteed by substantially all of the Company's wholly-owned subsidiaries that guarantee the senior secured credit facility and the Company's obligations under such notes are secured on a second priority basis by the same collateral as the senior secured credit facility.

The subsidiary guarantees related to the Company's senior secured credit facility and second priority bond issuances are full and unconditional and joint and several. Also, the parent company's assets and operations are not material and subsidiaries not guaranteeing the senior secured credit facility and bond issuances are minor. Accordingly, condensed consolidating financial information for the parent and subsidiaries is not presented.

14




8.    Retirement Plans

Net periodic pension expense recorded in the thirteen week periods ended May 29, 2004 and May 31, 2003, respectively, for the Company's defined benefit plans includes the following components:


  Defined Benefit
Pension Plan
Nonqualified Executive
Retirement Plan
  Thirteen Week Period Ended
  May 29,
2004
May 31,
2003
May 29,
2004
May 31,
2003
Service cost $ 1,350   $ 653   $ 17   $ 21  
Interest cost   1,200     1,153     246     346  
Expected return on plan assets   (1,250   (370        
Amortization of unrecognized net transition obligation           21     21  
Amortization of unrecognized prior service cost   175     113          
Amortization of unrecognized net loss   475     821     89     83  
Net pension expense $ 1,950   $ 2,370   $ 373   $ 471  

9.    Commitments and Contingencies

Legal Proceedings

Federal investigations

There are currently pending federal governmental investigations, both civil and criminal, by the United States Attorney, involving various matters related to prior management's business practices. The Company is cooperating fully with the United States Attorney. The Company has begun settlement discussions with the United States Attorney for the Middle District of Pennsylvania. The United States Attorney has proposed that the government would not institute any criminal proceeding against the Company if it enters into a consent judgment providing for a civil penalty payable over a period of years. The amount of the civil penalty has not been agreed to and there can be no assurance that a settlement will be reached or that the amount of such penalty will not have a material adverse effect on the Company's financial condition and results of operations. The Company has recorded an accrual of $20,000 in fiscal 2003 in connection with the resolution for these matters; however, the Company may incur charges in excess of that amount and is unable to estimate the possible range of loss. The Company will continue to evaluate its estimate and to the extent that additional information arises or the Company's strategy changes, the Company will adjust its accrual accordingly.

These investigations and settlement discussions are ongoing and the Company cannot predict their outcomes. If the Company was convicted of any crime, certain licenses and government contracts such as Medicaid plan reimbursement agreements that are material to the Company's operations may be revoked, which would have a material adverse effect on the Company's results of operations, financial condition or cash flows. In addition, substantial penalties, damages or other monetary remedies assessed against the Company, including a settlement, could also have a material adverse effect on the Company's results of operations, financial condition or cash flows.

15




Reimbursement Matters

The investigations conducted by multiple state attorney generals and the United States Department of Justice related to the Company's reimbursement practices for partially filled prescriptions and fully filled prescriptions that are not picked up by ordering customers have been concluded. In addition, the lawsuit filed in the United States District Court for the Eastern District of Pennsylvania under the Federal False Claims Act alleging that the Company defrauded federal healthcare plans by failing to appropriately issue refunds for partially filled prescriptions and prescriptions which were not picked up by customers has been settled. Under the agreement, in June 2004 the Company paid $7,225, which was previously accrued, to settle these matters. The Company believes that these investigations are similar to investigations that were undertaken with respect to the practices of others in the retail drug industry. The complaint will be dismissed with prejudice.

Other

The Company, together with a significant number of major U.S. retailers, has been sued by the Lemelson Foundation in a complaint that alleges that portions of the technology included in its point-of-sale system infringe upon a patent held by the plaintiffs. The amount of damages sought is unspecified and may be material. The Company cannot predict the outcome of this litigation or whether it could result in a material adverse effect on its results of operations, financial conditions or cash flows.

The Company is subject from time to time to lawsuits arising in the ordinary course of business. In the opinion of the Company, these matters are adequately covered by insurance or, if not so covered, are without merit or are of such nature or involve amounts that would not have a material adverse effect on its financial conditions, results of operations or cash flows if decided adversely.

10.    Subsequent Events

In June 2004, the Company repurchased $26,000 of its 7.125% notes due January 2007 and $12,000 of its 6.875% notes due December 2028. The Company will record a net gain on debt modifications and retirements of $1,586 on these transactions.

In June 2004, the Company adopted, upon receipt of shareholder approval, the 2004 Omnibus Equity Plan ("the Plan"). Under the Plan, 20,000 shares of common stock will be authorized for granting of restricted stock, stock options, phantom stock, stock bonus awards, and other equity based awards at the discretion of the Board of Directors.

11.    Restatement of Financial Statements

Subsequent to the issuance of the Company's condensed consolidated financial statements for the thirteen week period ended May 29, 2004, the Company's management reviewed certain of its lease related accounting policies. As a result of this review, the Company determined that its previous methods of accounting for straight-line rent expense and the related deferred rent liability and depreciation expense on leasehold improvements for a small number of stores were not in conformity with GAAP. As a result, the Company's financial statements for each of the three years in the period ended February 28, 2004 and for the first three quarters of fiscal 2005 have been restated.

Historically, the Company recorded rent expense on operating leases on a straight-line basis over the minimum lease term at the time that the store began operations. The Company has now determined that it should have recorded rent expense at the time that it had the right to use the property, which typically is when the Company begins construction on the property. The Company also had leasehold improvements at a small number of stores that were being depreciated over lives longer than the minimum lease term of the related ground lease. The Company has now determined that it should be amortizing these improvements over a life that is no longer than the minimum lease term. These non-cash adjustments have no impact on historical or future cash flows or the timing of payments under the Company's operating leases. Also, they have no impact on the Company's financial covenants under its senior secured credit facility.

The financial statement impact of the restatement is to recognize rent expense on operating leases on a straight-line method beginning at the time the Company has the right to use the property and to

16




accelerate the depreciation on the leasehold improvement assets that are on ground leases so that the asset is fully depreciated over the remaining minimum lease term. The cumulative effect of the restatement through the fiscal quarter ended May 29, 2004 is to decrease net property, plant and equipment by $1,119, to increase non-current liabilities by $16,036 and to increase the accumulated deficit by $17,155. The impact of the restatement is an increase in net income of $386 for the thirteen week period ended May 29, 2004 and a decrease in net loss of $81 for the thirteen week period ended May 31, 2003 from amounts previously reported. The restatement has no effect on diluted earnings per share for the thirteen weeks ended May 29, 2004 and May 31, 2003. The cumulative effect of the restatement for all years prior to fiscal 2002 was $19,184, which was recorded as an increase in opening stockholders' deficit at March 4, 2001.

A summary of the significant effects of the restatement on (i) the Company's condensed consolidated balance sheet as of May 29, 2004 and (ii) the Company's condensed consolidated statements of operations for the thirteen week periods ended May 29, 2004, and May 31, 2003 is as follows.

Balance sheet as of May 29, 2004


  As Previously
Reported
Adjustments As Restated
Property, plant and equipment, net $ 1,862,584   $ (1,119 $ 1,861,465  
Total assets   6,360,150     (1,119   6,359,031  
Non-current liabilities   863,266     16,036     879,302  
Total liabilities   6,281,652     16,036     6,297,688  
Accumulated deficit   (3,972,100   (17,155   (3,989,255
Total stockholders' equity   78,498     (17,155   61,343  
Total liabilities and stockholders' equity $ 6,360,150   $ (1,119 $ 6,359,031  

Income Statement — Thirteen Weeks Ended May 29, 2004


  As Previously
Reported
Adjustments As Restated
Cost of goods sold $ 3,191,834   $ (378 $ 3,191,456  
Store closing and impairment   (4,587   (8   (4,595
Total costs and expenses   4,175,975     (386   4,175,589  
Income before income taxes   68,382     386     68,768  
Net income $ 63,333   $ 386   $ 63,719  

Income Statement — Thirteen Weeks Ended May 31, 2003


  As Previously
Reported
Adjustments As Restated
Cost of goods sold $ 3,068,175   $ 39   $ 3,068,214  
Store closing and impairment   6,366     (120   6,246  
Total costs and expenses   4,084,990     (81   4,084,909  
Loss before income taxes   (38,822   81     (38,741
Net loss $ (38,822 $ 81   $ (38,741

17




ITEM 2.     Management's Discussion and Analysis of Financial Condition and Results of Operations

Overview

Net income for the thirteen week period ended May 29, 2004 was $63.7 million, compared to net loss of $38.7 million for the thirteen week period ended May 31, 2003. Increased revenues and improvements in gross margin and selling, general and administrative expenses ("SG&A") as a percent of sales all contributed to the improvement in our operating results, and are described in further detail in the Results of Operations section below. In addition, during the thirteen week period ended May 31, 2003, we recorded a loss on debt modifications and retirements of $33.4 million. This loss consisted of a loss of $43.2 million related to the termination of our then existing senior secured credit facility and the issuance of our current senior secured credit facility, offset by net gains of $9.8 million related to several debt instruments that were repurchased in the thirteen week period ended May 31, 2003. These transactions are described in more detail in the Liquidity and Capital Resources section below.

Restatement

The following Management's Discussion and Analysis of Financial Condition and Results of Operations gives effect to the restatement discussed in Note 11 to the condensed consolidated financial statements included in Item 1.

Results Of Operations

Revenues and Other Operating Data


  Thirteen Week Period Ended
  May 29,
2004
May 31,
2003
  (dollars in thousands)
Revenues $ 4,244,357   $ 4,046,168  
Revenue growth   4.9   3.1
Same store sales growth   5.3   4.3
Pharmacy sales growth   5.0   4.6
Same store pharmacy sales growth   5.4   5.7
Pharmacy sales as a % of total sales   64.6   64.5
Third party sales as a % of total pharmacy sales   93.7   93.1
Front-end sales growth   4.7   0.5
Same store front-end sales growth   5.2   1.8
Front-end sales as a % of total sales   35.4   35.5
Store data:            
Total stores (beginning of period)   3,382     3,404  
New stores        
Closed stores   (9   (8
Store acquisitions, net   1      
Total stores (end of period)   3,374     3,396  
Remodeled stores   48     41  
Relocated stores   3     1  

Revenues

The 4.9% growth in revenues for the thirteen week period ended May 29, 2004, was driven by pharmacy sales growth of 5.0% and front end sales growth of 4.7%. The pharmacy sales growth is from a same store sales increase of 5.4% for the thirteen week period ended May 29, 2004, due to an increase in price per prescription. This increase was driven by inflation and a shift in Memorial Day, partially offset by an increase in generic sales mix. Partially offsetting the increase in price per prescription was a slight

18




decrease in the number of prescriptions filled, due primarily to the impact of a weaker cold and flu season, certain third party payors requiring customers to use mail order for certain prescriptions and a reduction in hormone therapy prescriptions. Front-end sales growth is from a same store sales increase of 5.2% in the thirteen week period ended May 29, 2004, primarily as a result of improvement in most core categories, such as over-the-counter items, consumables and vitamins, and improved assortments.

Pharmacy and front-end same store sales increases in the thirteen week period ended May 29, 2004, benefited from increased business in our Southern California stores, driven by the migration of customers impacted by a union strike at several grocery store chains. The union strike ended in March 2004. We have been successful in retaining a significant amount of the customers in the pharmacy and front-end parts of our business.

The 3.1% growth in revenues for the thirteen week period ended May 31, 2003 was driven by pharmacy sales growth of 4.6% and front-end sales growth of 0.5%. The pharmacy sales growth is from an increase in same store sales of 5.7% for the thirteen week period ended May 31, 2003, due to an increase in sales price per prescription, partially offset by a change in prescription mix. The increase in sales price per prescription was driven by inflation and favorable industry trends. The positive impact of the change in price per prescription was offset by an increase in the generic sales mix, a reduction in hormone therapy and non-sedating antihistamine prescriptions, the impact of a less severe cold and flu season than in the prior year, and a slow start to the allergy season. Front-end sales growth is from a same store sales increase of 1.8% in the thirteen week period ended May 31, 2003, primarily as a result of improvement in most core categories and improved assortments.

Costs and Expenses


  Thirteen Week Period Ended
  May 29,
2004
May 31,
2003
  (dollars in thousands)
Cost of goods sold, including occupancy costs $ 3,191,456   $ 3,068,214  
Gross profit   1,052,901     977,954  
Gross margin   24.8   24.2
Selling, general and administrative expenses   908,863     889,733  
Selling, general and administrative expenses as a percentage
of revenues
  21.4   22.0
Stock-based compensation expense   3,982     9,835  
Store closing and impairment charges (credits)   (4,595   6,246  
Interest expense   77,801     78,958  
Loss on debt modifications and retirements, net       33,427  
Gain on sale of assets and investments, net   (1,918   (1,504

Cost of Goods Sold

Gross margin was 24.8% for the thirteen week period ended May 29, 2004, compared to 24.2% for the thirteen week period ended May 31, 2003. Gross margin was positively impacted by improvements in pharmacy margin, which was driven by improved generic product mix and reduced inventory costs resulting from purchasing improvements. These items were partially offset by lower reimbursement rates. Gross margin was also positively impacted by flat occupancy costs on a higher sales base and lower LIFO related charges. These items offset a slight decline in front-end margin rate, which was primarily due to a decrease in one-hour photo gross margin.

We use the last-in, first out (LIFO) method of inventory valuation, which is determined annually when inflation rates and inventory levels are finalized. Therefore, LIFO costs for interim period financial statements are estimated. Cost of sales include a LIFO provision of $10.7 million for the thirteen week period ended May 29, 2004 versus $15.0 million for the thirteen week period ended May 31, 2003.

Selling, General and Administrative Expenses

SG&A expenses were 21.4% as a percentage of revenues for the thirteen week period ended May 29, 2004 compared to 22.0% for the thirteen week period ended May 31, 2003. The improvement in SG&A

19




expenses as a percentage of revenues for the thirteen week period ended May 29, 2004 was due to better leveraging of our salary and fixed costs resulting from higher revenues and decreased depreciation and amortization charges resulting from certain store equipment and intangible assets becoming completely depreciated and amortized. Also contributing to the improvement in SG&A as a percentage of revenues was the timing of holiday pay related to the Memorial Day holiday, which is included in the thirteen week period ended May 31, 2003. Holiday pay related to the current year Memorial Day holiday will be incurred in the thirteen week period ending August 28, 2004.

Stock-Based Compensation Expense

We recorded stock-based compensation expense of $4.0 million and $9.8 million in the thirteen week periods ended May 29, 2004 and May 31, 2003, respectively. The reduction in expense in the thirteen week period ended May 29, 2004 is due to awards granted in prior years becoming fully vested.

Store Closing and Impairment Charges

Store closing and impairment (credits) charges consist of:


  Thirteen Week Period Ended
  May 29,
2004
May 31,
2003
  (dollars in thousands)
Impairment charges $ 829   $ 831  
Store and equipment lease exit charges (credits)   (5,424   5,415  
  $ (4,595 $ 6,246  

Impairment Charges:    Impairment charges include non-cash charges of $0.8 million and $0.8 million in the thirteen week periods ended May 29, 2004 and May 31, 2003, respectively, for the impairment of long-lived assets at 11 stores, in each period. These amounts include the write-down of long-lived assets at stores that were assessed for impairment because of management's intention to relocate or close the store.

Store and Equipment Lease Exit (Credits) Charges:    During the thirteen week periods ended May 29, 2004 and May 31, 2003, we recorded charges for one closed store in each period. Charges to close a store, which principally consist of lease termination costs, are recorded at the time the store is closed and all inventory is liquidated, pursuant to the guidance set forth in SFAS No. 146, "Accounting for Costs Associated with Exit or Disposal Activities". We calculate our liability for closed stores on a store-by-store basis. The calculation includes the future minimum lease payments and related ancillary costs, from the date of closure to the end of the remaining lease term, net of estimated cost recoveries that may be achieved through subletting properties or favorable lease terminations. This liability is discounted using a risk free rate of interest. We evaluate these assumptions each quarter and adjust the liability accordingly. We recorded a closed store credit of $5.4 million in the thirteen week period ended May 29, 2004, due primarily to the impact of adjustments to the risk-free rate of interest on the provision. We recorded closed store expense of $5.4 million in the thirteen week period ended May 31, 2003, due to the impact of interest accretion and adjustments to the risk-free rate of interest on the provision.

As part of our ongoing business activities, we assess stores for potential closure. Decisions to close stores in future periods would result in charges for store lease exit costs and liquidation of inventory, as well as impairment of assets at these stores.

Interest Expense

Interest expense was $77.8 million for the thirteen week period ended May 29, 2004, compared to $79.0 million for the thirteen week period ended May 31, 2003. The decrease in interest expense was due to a decrease in debt issue cost amortization. The weighted average interest rates, excluding capital leases, on our indebtedness for the thirteen week periods ended May 29, 2004 and May 31, 2003 were 6.77% and 6.87%, respectively.

20




Income Taxes

The provision for income taxes for the thirteen week period ended May 29, 2004 of $5.0 million is for state and local income taxes. The expected federal income tax expense has been fully offset by utilization of net operating loss carryforwards resulting in the reduction of previously recorded valuation allowances.

The income tax benefit of the operating loss generated in the thirteen week period ended May 31, 2003 has been fully offset by a valuation allowance as a result of our determination that, based on available evidence, it is more likely than not that the deferred tax assets will not be realized.

We experienced an ownership change for statutory purposes during fiscal 2002, which resulted in a limitation on the future use of net operating loss carryforwards. We believe that this limitation does not further impair the net operating loss carryforwards because they are fully reserved.

Liquidity and Capital Resources

General

We have three primary sources of liquidity: (i) cash equivalent investments, (ii) cash provided by operations and (iii) the revolving credit facility under our senior secured credit facility. Our principal uses of cash are to provide working capital for operations, service our obligations to pay interest and principal on debt, to provide funds for capital expenditures and to provide funds for repurchases of our publicly traded debt.

Credit Facility

Our senior secured credit facility consists of a $1.15 billion term loan and a $700.0 million revolving credit facility, and will mature on April 30, 2008. Our ability to borrow under the senior secured credit facility is based on a specified borrowing base consisting of eligible accounts receivable, inventory and prescription files. On May 29, 2004, we had $573.2 million in additional available borrowing capacity under the revolving credit facility net of outstanding letters of credit of $126.8 million.

Substantially all of Rite Aid Corporation's wholly owned subsidiaries guarantee the obligations under the senior secured credit facility. The subsidiary guarantees are secured by a first priority lien on, among other things, the inventory, accounts receivable and prescription files of the subsidiary guarantors. Rite Aid Corporation is a holding company with no direct operations and is dependent upon dividends, distributions and other payments from its subsidiaries to service payments under the senior secured credit facility. Rite Aid Corporation's direct obligations under the senior secured credit facility are unsecured.

The senior secured credit facility allows for the issuance of up to $150.0 million in additional term loans or additional revolver availability. We may request the additional loans at any time prior to the maturity of the senior secured credit facility, provided we are not in default of any terms of the facility, nor are in violation of any financial covenants. The senior secured credit facility allows us to have outstanding, at any time, up to $1.0 billion in secured debt, in addition to the senior secured credit facility. At May 29, 2004, the remaining additional permitted secured debt under the senior secured credit facility is $198.0 million. We also have the ability to incur an unlimited amount of unsecured debt, if the terms of such unsecured indebtedness comply with certain terms set forth in the credit agreement and subject to our compliance with certain financial covenants. If we issue unsecured debt that does not meet the credit agreement restrictions, it reduces the amount of available permitted secured debt. The senior secured credit facility also allows for the repurchase of any debt with a maturity prior to April 30, 2008, and for $200.0 million of debt with a maturity after April 30, 2008, plus an additional amount based upon outstanding borrowings under the revolving credit facility and available cash at the time of the repurchase.

The senior secured credit facility contains customary covenants, which place restrictions on the incurrence of debt, the payment of dividends, mergers, liens and sale and leaseback transactions. The senior secured credit facility also requires us to meet various financial ratios and limits capital expenditures. For the twelve months ending February 26, 2005, the covenants require us to maintain a maximum leverage ratio of 6.05:1. Subsequent to February 26, 2005, the ratio gradually decreases to 3.80:1

21




for the twelve months ending March 1, 2008. We must also maintain a minimum interest coverage ratio of 2.05:1 for the twelve months ending February 26, 2005. Subsequent to February 26, 2005, the ratio gradually increases to 3.25:1 for the twelve months ending March 1, 2008. In addition, we must maintain a minimum fixed charge ratio of 1.10:1 for the twelve months ending February 26, 2005. Subsequent to the twelve months ending February 26, 2005, the ratio gradually increases to 1.25:1 for the twelve months ending March 1, 2008. Capital expenditures are limited to $386.1 million for the fiscal year ending February 26, 2005, with the allowable amount increasing in subsequent years.

We were in compliance with the covenants of the senior secured credit facility and our other debt instruments as of May 29, 2004. With continuing improvements in operating performance, we anticipate that we will remain in compliance with our debt covenants. However, variations in our operating performance and unanticipated developments may adversely affect our ability to remain in compliance with the applicable debt maintenance covenants.

The senior secured credit facility provides for customary events of default, including nonpayment, misrepresentation, breach of covenants and bankruptcy. It is also an event of default if any event occurs that enables, or which with the giving of notice or the lapse of time would enable, the holder of our debt to accelerate the maturity of debt having a principal amount in excess of $25.0 million.

Other Transactions

In June 2004, we repurchased $26.0 million of our 7.125% notes due January 2007 and $12.0 million of our 6.875% notes due December 2028. We will record a net gain on debt modifications and retirements of $1.6 million on these transactions.

During the thirteen week period ended May 31, 2003, we repurchased the following securities (in thousands):


Debt Repurchased Principal
Amount
Repurchased
Amount Paid Gain
6.0% fixed rate senior notes due 2005 $ 37,848   $ 36,853   $ 865  
7.125% notes due 2007   124,926     120,216     4,314  
6.875% senior debentures due 2013   15,227     13,144     1,981  
7.7% notes due 2027   5,000     4,219     715  
6.875% fixed rate senior notes due 2028   10,000     7,975     1,895  
Total $ 193,001   $ 182,407   $ 9,770  

The gain on the transactions listed above is recorded as part of the loss on debt modification in the accompanying statement of operations for the thirteen week period ended May 31, 2003.

The aggregate annual principal payments of long-term debt for the remainder of fiscal 2005 and the succeeding four fiscal years are as follows: 2005-$9.0 million, 2006-$250.8 million, 2007-$606.6 million, 2008-$12.4 million, 2009-$1,404.1 million, and $1,424.1 million in 2010 and thereafter.

Other

As of May 29, 2004, we had no material off balance sheet arrangements. Our contractual obligations and commitments, which consist primarily of debt, capital and operating leases, open purchase orders, lease guarantees, and outstanding letters of credit have not changed materially from the amounts disclosed in our Fiscal 2004 10-K/A.

Net Cash Provided by/Used in Operating, Investing and Financing Activities

Our operating activities provided $216.6 million of cash in the thirteen week period ended May 29, 2004 and provided $49.8 million of cash in the thirteen week period ended May 31, 2003. Operating cash flow for the thirteen week period ended May 29, 2004 was provided through improved operating results, income tax refunds of $36.0 million, increases in accounts payables and decreases in accounts receivable,

22




which offset $52.2 million in interest payments and increases in inventory. Operating cash flow for the thirteen week period ended May 31, 2003 was provided through improved operating results and increases in accounts payable, which offset $61.2 million of interest payments and increases in accounts receivable and inventory.

Cash used in investing activities was $38.3 million for the thirteen week period ended May 29, 2004 due to expenditures for property, plant and equipment and intangible assets, offset by proceeds from asset dispositions. Cash used in investing activities was $125.1 million for the thirteen week period ended May 31, 2003, due primarily to the purchase of land and buildings at our Perryman, MD and Lancaster, CA distribution centers, which had previously been held under a synthetic lease arrangement. Also impacting cash used in investing activities were expenditures for property, plant and equipment as well as intangible assets, offset by proceeds from asset dispositions.

Cash used in financing activities was $12.8 million for the thirteen week period ended May 29, 2004, due to the impact of scheduled debt payments and the change in zero balance cash accounts. Cash provided by financing activities was $52.8 million for the thirteen week period ended May 31, 2003. Cash provided by financing activities in the thirteen week period ended May 31, 2003 was positively impacted by proceeds from bond issuances, offset by the change in our credit facility and the repurchase of several bonds.

Capital Expenditures

During the thirteen week period ended May 29, 2004, we incurred capital expenditures of $41.8 million consisting of $19.4 million related to new store construction, store relocation and other store construction projects. An additional $22.4 million was related to other store improvement activities and the purchase of prescription files from independent pharmacists. We plan to make total capital expenditures of approximately $275 to $325 million during fiscal 2005. These expenditures consist of approximately $175 to $205 million related to new store construction, store relocation and store remodel projects, $70 to $80 million dedicated to technology enhancements, improvements to distribution centers and other corporate requirements, and $30 to $40 million dedicated to the purchase of prescription files from independent pharmacies. Management expects that these capital expenditures will be financed primarily with cash flow from operations. During the thirteen week period ended May 31, 2003, we spent $133.7 million on capital expenditures, consisting of $11.0 million related to new store construction, store relocation and other store construction projects. An additional $15.8 million was related to other store improvement activities and the purchase of prescription files from independent pharmacists. Additionally, during the thirteen week period ended May 31, 2003, we incurred capital expenditures of $106.9 million related to the purchase of land and buildings at our Perryman, MD and Lancaster, CA distribution centers, which had previously been held under a synthetic lease arrangement.

Future Liquidity

We are highly leveraged. Our high level of indebtedness: (i) limits our ability to obtain additional financing; (ii) limits our flexibility in planning for, or reacting to, changes in our business and the industry; (iii) places us at a competitive disadvantage relative to our competitors with less debt; (iv) renders us more vulnerable to general adverse economic and industry conditions; and (v) requires us to dedicate a substantial portion of our cash flow to service our debt. Based upon current levels of operations and planned improvements in our operating performance, management believes that cash flow from operations together with cash equivalent investments and available borrowing under the senior secured credit facility and other sources of liquidity will be adequate to meet our anticipated annual requirements for working capital, debt service and capital expenditures through the end of fiscal 2005. We will continue to assess our liquidity position and potential sources of supplemental liquidity in light of our operating performance and other relevant circumstances. Should we determine, at any time, that it is necessary to seek additional short-term liquidity, we will evaluate our alternatives and take appropriate steps to obtain sufficient additional funds. The restrictions on the incurrence of additional indebtedness in our senior secured credit facility and several of our bond indentures may limit our ability to obtain additional funds. There can be no assurance that any such supplemental funding, if sought, could be obtained or, if obtained, would be on terms acceptable to us.

23




Recent Accounting Pronouncements

In January of 2003, the FASB issued FIN No. 46, "Consolidation of Variable Interest Entities", subject to certain effective date deferrals. FIN No. 46 requires the consolidation of entities that cannot finance their activities without the support of other parties and that lack certain characteristics of a controlling interest, such as the ability to make decisions about the entity's activities via voting rights or similar rights. The entity that consolidates the variable interest entity is the primary beneficiary of the entity's activities. FIN No. 46 applies immediately to variable interest entities created after January 31, 2003, and must be applied in the first period ending after December 15, 2003 for entities in which an enterprise holds a variable interest entity that it acquired before February 1, 2003. The adoption of FIN No. 46 did not have a material impact on our financial position or results of operations. In December of 2003, the FASB revised FIN 46 ("FIN 46R"), which delayed the required implementation date for variable interest entities until the end of the first reporting period that ends after March 15, 2004. FIN 46R applied to our financial statements for the period ended May 29, 2004. The adoption of FIN 46R did not have a material impact on our financial position or results of operations.

Factors Affecting Our Future Prospects

For a discussion of risks related to our financial condition, operations and industry, refer to "Management's Discussion and Analysis of Financial Condition and Results of Operations Overview" and "Factors Affecting our Future Prospects" included in our Annual Report on Form 10-K/A for the fiscal year ended February 28, 2004.

ITEM 3.    Quantitative and Qualitative Disclosures About Market Risk

Our future earnings, cash flow and fair values relevant to financial instruments are dependent upon prevalent market rates. Market risk is the risk of loss from adverse changes in market prices and interest rates. The major market risk exposure is changing interest rates. Increases in interest rates would increase our interest expense. Since the end of fiscal 2004, our primary risk exposure has not changed. We enter into debt obligations to support capital expenditures, acquisitions, working capital needs and general corporate purposes. Our policy is to manage interest rates through the use of a combination of variable-rate credit facilities, fixed-rate long-term obligations and derivative transactions.

The table below provides information about our financial instruments that are sensitive to changes in interest rates. The table presents principal payments and the related weighted average interest rates by expected maturity dates as of May 29, 2004.


  2005 2006 2007 2008 2009 Thereafter Total Fair
Value
at May 29,
2004
  (dollars in thousands)
Long-term debt, Including current portion
Fixed rate $ 377   $ 236,419   $ 595,149   $ 871   $ 300,092   $ 1,424,144   $ 2,557,052   $ 2,555,705  
Average Interest Rate   8.00   7.36   7.50   8.00   8.69   8.20   8.01
Variable Rate   8,625   $ 14,375   $ 11,500   $ 11,500   $ 1,104,000   $   $ 1,150,000   $ 1,150,000  
Average Interest Rate   4.10   4.10   4.10   4.10   4.10     4.10
 

As of May 29, 2004, 29.6% of our total debt is subject to fluctuations in variable interest rates.

Our ability to satisfy interest payment obligations on our outstanding debt will depend largely on our future performance, which, in turn, is subject to prevailing economic conditions and to financial, business and other factors beyond our control. If we do not have sufficient cash flow to service our interest payment obligations on our outstanding indebtedness and if we cannot borrow or obtain equity financing to satisfy those obligations, our business and results of operations will be materially adversely affected. We cannot assure you that any such borrowing or equity financing could be successfully completed.

As of May 29, 2004, the ratings on our new senior secured credit facility were BB by Standard & Poor's and Ba3 by Moody's. The interest rate on the variable rate borrowings on this facility are LIBOR plus 3.00% for the term loan and 3.50% for the revolving credit facility.

24




ITEM 4.    Controls and Procedures

Disclosure Controls and Procedures.    On February 7, 2005, a letter was issued by the Office of the Chief Accountant of the SEC to the American Institute of Certified Public Accountants that clarified the application of GAAP for lease accounting. The SEC letter led to a review of our lease-related accounting practices. As a result of our review, we have determined that our previous methods of accounting for straight-line rent expense and the related deferred rent liability and leasehold improvement depreciation for a small number of stores were not in conformity with GAAP.

On March 17, 2005, our management and audit committee determined to restate our financial statements for each of the three years in the period ended February 28, 2004 and for the first three quarters of fiscal 2005 and to file a Form 10-K/A amending our Annual Report on Form 10-K for our fiscal year ended February 28, 2004 with restated consolidated financial statements and Forms 10-Q/A amending our interim condensed consolidated financial statements for the first three quarters of fiscal 2005. The restatement is further discussed in "Explanatory Note" in the forepart of this Form 10-Q/A and in Note 11, "Restatement of Financial Statements," to the accompanying condensed consolidated financial statements.

In connection with the restatement referred to above, our management, including our Chief Executive Officer and Chief Financial Officer, re-evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) as of the end of the period covered by this report (May 29, 2004). Based on this evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this Form 10-Q/A, our disclosure controls and procedures were effective in recording, processing, summarizing and reporting, on a timely basis, the information relating to us required to be disclosed by us in the reports that we file or submit under the Exchange Act and are effective in ensuring that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

In concluding that our disclosure controls and procedures were effective as of May 29, 2004, our management considered, among other things, the circumstances that resulted in the restatement of our previously issued financial statements. We also considered the materiality of the restatement adjustments on our consolidated balance sheet and statement of operations (as more fully set forth Note 11, "Restatement of Financial Statements," to the accompanying condensed consolidated financial statements) and that these non-cash adjustments have no effect on historical or future cash flows or the timing of payments under our operating leases.

Changes In Internal Control Over Financial Reporting.    There have not been any changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

25




PART II. OTHER INFORMATION

ITEM 1.    Legal Proceedings

The investigations conducted by multiple state attorneys general and the United States Department of Justice related to our reimbursement practices for partially filled prescriptions and fully filled prescriptions that are not picked up by ordering customers have been concluded. In addition, the lawsuit filed in the United States District Court for the Eastern District of Pennsylvania under the Federal False Claims Act alleging that we defrauded federal healthcare plans by failing to appropriately issue refunds for partially filled prescriptions and prescriptions which were not picked up by customers has been settled. Under the settlement agreement we paid $7.2 million in June 2004, which was previously accrued. We believe that these investigations are similar to investigations that were undertaken with respect to the practices of others in the retail drug industry. The complaint will be dismissed with prejudice.

ITEM 2.    Changes in Securities, Use of Proceeds and Issuer Purchases of Equity Securities

We have not sold any unregistered equity securities covered by this report, nor have we repurchased any equity securities during the period covered by this report.

ITEM 3.    Defaults Upon Senior Securities

Not applicable.

ITEM 4.    Submission of Matters to a Vote of Security Holders

No matters were submitted to a vote of the security holders during the thirteen week period ended May 29, 2004.

ITEM 5.    Other Information

Not applicable.

26




ITEM 6.    Exhibits and Reports on Form 8-K

(a) The following exhibits are filed as part of this report.


Exhibit
Numbers
Description Incorporation By
Reference To
 
3.1 Restated Certificate of Incorporation dated December 12, 1996 Exhibit 3(i) to Form 8-K, filed on November 2, 1999    
3.2 Certificate of Amendment to the Restated Certificate of Incorporation dated February 22, 1999 Exhibit 3(ii) to Form 8-K, filed on November 2, 1999    
3.3 Certificate of Amendment to the Restated Certificate of Incorporation dated June 27, 2001 Exhibit 3.4 to Registration Statement on Form S-1, File No. 333-64950, filed on July 12, 2001    
3.4 8% Series D Cumulative Pay-in-Kind Preferred Stock Certificate of Designation dated October 3, 2001 Exhibit 3.5 to Form 10-Q, filed on
October 12, 2001
   
3.5 By-laws, as amended on November 8, 2000 Exhibit 3.1 to Form 8-K, filed on November 13, 2000    
3.6 Amendment to By-laws, adopted January 30, 2002 Exhibit T3B.2 to Form T-3, filed on March 4, 2002    
4.1 Indenture, dated August 1, 1993 by and between Rite Aid Corporation, as issuer, and Morgan Guaranty Trust Company of New York, as trustee, related to the Company's 6.70% Notes due 2001, 7.125% Notes due 2007, 7.70% Notes due 2027, 7.625% Notes due 2005 and 6.875% Notes due 2013 Exhibit 4A to Registration Statement on Form S-3, File No. 333-63794, filed on June 3, 1993    
4.2 Supplemental Indenture dated as of February 3, 2000, between Rite Aid Corporation, as issuer, and U.S. Bank Trust National Association as successor to Morgan Guaranty Trust Company of New York,, to the Indenture dated as of August 1, 1993, relating to the Company's 6.70% Notes due 2001, 7.125% Notes due 2007, 7.70% Notes due 2027, 7.625% Notes due 2005 and 6.875% Notes due 2013 Exhibit 4.1 to Form 8-K filed on
February 7, 2000
   
4.3 Indenture, dated as of December 21, 1998, between Rite Aid Corporation, as issuer, and Harris Trust and Savings Bank, as trustee, related to the Company's 5.50% Notes due 2000, 6% Notes due 2005, 6.125% Notes due 2008 and 6.875% Notes due 2028 Exhibit 4.1 to Registration Statement on Form S-4, File No. 333-74751, filed on March 19, 1999    
4.4 Supplemental Indenture, dated as of February 3, 2000, between Rite Aid Corporation and Harris Trust and Savings Bank, to the Indenture dated December 21, 1998, between Rite Aid Corporation and Harris Trust and Savings Bank, related to the Company's 5.50% Notes due 2000, 6% Notes due 2005, 6.125% Notes due 2008 and 6.875% Notes due 2028 Exhibit 4.4 to Form 8-K, filed on
February 7, 2000
   

27





Exhibit
Numbers
Description Incorporation By
Reference To
 
4.5 Indenture, dated as of June 27, 2001, between Rite Aid Corporation, as issuer and State Street Bank and Trust Company, as trustee, related to the Company's 12.50% Senior Secured Notes due 2006 Exhibit 4.7 to Registration Statement on Form S-1, File No. 333-64950, filed on July 12, 2001    
4.6 Indenture, dated as of June 27, 2001 between Rite Aid Corporation, as issuer and BNY Midwest Trust Company, as trustee, related to the Company's 11 ¼% Senior Notes due 2008 Exhibit 4.8 to Registration Statement on Form S-1, File No. 333-64950, filed on July 12, 2001    
4.7 Indenture, dated as of November 19, 2001, between Rite Aid Corporation, as issuer, and BNY Midwest Trust Company, as trustee, related to the Company's 4.75% Convertible Notes due December 1, 2006 Exhibit 4.3 to Form 10-Q, filed on
January 15, 2002
   
4.8 Indenture, dated as of February 12, 2003, between Rite Aid Corporation, as issuer, and BNY Midwest Trust Company, as trustee, Related to the Company's 9½% Senior Secured Notes due 2011 Exhibit 4.1 to Form 8-K, filed on
March 5, 2003
   
4.9 Indenture, dated as of April 22, 2003, between Rite Aid Corporation, as issuer, and BNY Midwest Trust Company, as trustee, related to the Company's 8.125% Senior Secured Notes due 2010 Exhibit 4.11 to Form 10-K, filed on
May 2, 2003
   
4.10 Indenture, dated as of May 20, 2003, between Rite Aid Corporation, as issuer, and BNY Midwest Trust Company, as trustee, related to the Company's 9.25% Senior Notes due 2013 Exhibit 4.12 to Form 10-Q, filed on July 3, 2003    
11 Statement regarding computation of earnings per share. (See Note 3 to the condensed consolidated financial statements) Filed herewith    
31.1 Certification of CEO pursuant to Rule 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934. Filed herewith    
31.2 Certification of CFO pursuant to Rule 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934. Filed herewith    
32 Certification of CEO and CFO pursuant to 18 United States Code, Section 1350, as adopted persuant to Section 906 of the Sarbanes-Oxley Act of 2002 Filed herewith
   

Rite Aid filed the following current reports on Form 8-K during the thirteen week period ended May 29, 2004:

1.    Rite Aid Corporation did not file any Current Reports on Form 8-K during the thirteen week period ended May 29, 2004.

28




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Date: April 6, 2005 RITE AID CORPORATION
By:  /s/ ROBERT B. SARI
Robert B. Sari
Senior Vice President and
General Counsel
Date: April 6, 2005 By:  /s/ JOHN T. STANDLEY
John T. Standley
Senior Executive Vice President,
Chief Administrative Officer, and
Chief Financial Officer

29